Related Experiment Video
Updated: Aug 16, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Circulating Biomarkers for Laboratory Diagnostics of Atherosclerosis-Literature Review
Gabriela Bordeianu1, Ivona Mitu1, Raluca Stefania Stanescu1
1Department of Morpho-Functional Sciences II, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
Insights
This study reviews biomarkers for atherosclerosis, a cardiovascular disease. It highlights the link between lipid profiles, inflammation, and early vascular lesion detection for better patient management.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Molecular Pathophysiology
Background:
- Atherosclerosis poses a significant long-term burden on the cardiovascular system.
- Effective management relies on traditional and emerging biomarkers to assess disease progression.
- Detecting incipient vascular lesions requires advanced predictive marker models.
Purpose of the Study:
- To analyze recent literature on molecular mechanisms of biomarkers in atherosclerosis.
- To understand the role of biomarkers in the atherosclerotic cascade.
- To explore the linkage between lipid profiles, inflammation, and disease evolution.
Main Methods:
- Literature review of recent data.
- Analysis of molecular mechanisms of biomarkers.
- Investigation of biomarker involvement in atherosclerotic pathophysiology.
Main Results:
- Advances have strengthened the understanding of the lipid profile-inflammation link.
- Biomarkers are crucial for evaluating atherosclerotic stages and early lesions.
- The study synthesizes current knowledge on molecular pathways.
Conclusions:
- Biomarker research is vital for understanding and managing atherosclerosis.
- Improved predictive models are needed for early vascular lesion detection.
- A comprehensive view of lipid-inflammation interplay aids therapeutic strategies.
Abstract:
Atherosclerosis is still considered a disease burden with long-term damaging processes towards the cardiovascular system. Evaluation of atherosclerotic stages requires the use of independent markers such as those already considered traditional, that remain the main therapeutic target for patients with atherosclerosis, together with emerging biomarkers. The challenge is finding models of predictive markers that are particularly tailored to detect and evaluate the evolution of incipient vascular lesions. Important advances have been made in this field, resulting in a more comprehensible and stronger linkage between the lipidic profile and the continuous inflammatory process. In this paper, we analysed the most recent data from the literature studying the molecular mechanisms of biomarkers and their involvement in the cascade of events that occur in the pathophysiology of atherosclerosis.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

